FEATURED NEWS

MATEC
March 24, 2017
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV Infected Adults and Adolescents document was published in an electronic format that could be easily updated as relevant changes in prevention and MORE
MATEC
July 14, 2016
New CDC MMWR report on antibiotic-resistant gonorrhea includes concerning findings for azithromycin - one of two drugs in the only recommended treatment regimen Centers for Disease Control and Prevention (CDC), July 14, 2016. On July 14, 2016 CDC, On July 14, 2016, the Centers for Disease Control and Prevention (CDC) MMWR report titled Neisseria MORE
FDA
March 24, 2016
Update: Meningococcal Vaccine Recommendations March 18th, Chicago Department of Public Health. The Chicago Department of Public Health (CDPH) is investigating a new case of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup C reported in March 2016, 9 months following the last case tied to a Chicago-area outbreak of serogroup MORE
FDA
March 4, 2016
Updated HHS Pediatric Antiretroviral Treatment Guidelines Released >Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral, Department of Health and Human Services. Updated March 1, 2016 The HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children announces MORE
FDA
February 1, 2016
U.S. Food and Drug Administration, January 28, 2016 The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is a viral disease that causes inflammation of the liver that can lead to MORE